Article Details

Merck acquires OncoImmune to ramp supply of promising Covid drug

Retrieved on: 2020-11-23 11:46:45

Tags for this article:

Click the tags to see associated articles and topics

Merck acquires OncoImmune to ramp supply of promising Covid drug. View article details on hiswai:

Excerpt

The medicine, called CD24Fc, was shown to reduce the risk of respiratory failure or death by more than 50% in patients hospitalized with <b>Covid</b> and ...

Article found on: www.cnbc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo